semaglutide news october 16 2025 Use of linked to doubled risk of neovascular macular degeneration Semaglutide: Shedding pounds, weighing risks

Zilbrysq is a novel macrocyclic peptide of a C5 complement inhibitor that can be used to treat adult patients with generalized myasthenia gravis (gMG) with positive anti-acetylcholine receptor (AChR) antibodies

The effectiveness of GLP-1 agonists for weight loss will depend on the brand or active ingredient

Follow-up appointments can partly be handled remotely we tailor the plan to your situation

At 0.75mg, fasting blood glucose often shows measurable improvement, and satiety mechanisms activate more robustly across both meals and between-meal periods

Stop bupropion right away and seek immediate medical attention if you experience symptoms of an allergic reaction

Some viewers questioned whether the side effects outweighed the benefits, and others expressed discomfort with celebrity endorsements in a medical context